Pradelli, L., Villa, S., & Castaman, G. (2018). Albutrepenonacog alfa (Idelvion®) for the treatment of Italian patients with hemophilia B: a budget impact model. Farmeconomia. Health Economics and Therapeutic Pathways, 19(1). https://doi.org/10.7175/fe.v19i1.1328